Topic: Amgen Inc.
Reuters US Online Report Health News | 2010-03-02 20:45:06
CHICAGO (Reuters) - Aggressive treatment with blockbuster anemia drugs may offer the best approach for kidney dialysis patients with severe anemia, U.S. researchers said on Tuesday. But aggressive treatment only made things worse for patients in the final stages of kidney disease with mild anemia, they reported in the Journal of the American Medical Association. The findings may help guide ...
AP News | 2010-02-16 14:54:02
<div id="subtitle">FDA plan requires Amgen, J&amp;J to educate doctors and patients on risks of anemia drugs</div><div><p>Amgen and Johnson &amp; Johnson will be required to publicize the life-threatening risks of their anemia drugs, under the latest government-imposed safety precautions to snare the blockbuster ...
AP News | 2010-02-09 14:59:37
<div id="subtitle">Amgen says potential bone drug tops rival in late-stage study on prostate cancer patients</div><div><p>Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.</p>< ...
Reuters US Online Report Business News | 2010-01-25 22:27:51
<div><p>NEW YORK (Reuters) - Amgen Inc &lt;AMGN.O&gt; issued a 2010 forecast on Monday that showed potential to exceed Wall Street expectations, but the company's slightly higher fourth-quarter profit came in shy of analyst estimates primarily due to higher expenses.</p><p>The world's largest ...
